Nov 4 (Reuters) - Audit firm BDO must face a securities fraud claim by a class of AmTrust Financial shareholders after a federal appeals court took the rare step last week of revisiting a decision ...

RELATED: EU backs fully subcutaneous regimen of Remicade biobetter “The post-hoc analysis indicates that switching from IV to SC infliximab will deliver comparable clinical outcomes for patients ...

Johnson & Johnson’s attempt to switch physicians from intravenous to subcutaneous Darzalex is almost complete. Having won FDA approval for Darzalex Faspro in May 2020, J&J has converted 85% of ...

A subcutaneous formulation of Johnson & Johnson’s BCMAxCD3 bispecific antibody teclistamab has achieved a 73% overall response rate in a small trial of heavily pretreated multiple myeloma ...